Coronavirus Vaccine Update With Paul Offit and Robert Wachter
Coronavirus Vaccine Update With Paul Offit and Robert Wachter
To get more vaccine to more people more efficiently, @UCSF School of Medicine's Robert M. Wachter, MD recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD of @The Children's Hospital of Philadelphia disagrees.The two discuss the pros and the cons of the plan, and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A series. Recorded January 19, 2020.
Read Dr. Wachter's @Washington Post proposal at
https://www.washingtonpost.com/opinions/2021/01/03/its-time-consider-delaying-second-dose-coronavirus-vaccine/
Topics discussed in this interview:
0:00 Introduction
0:56 Reasoning behind delaying 2nd vaccine dose
4:21 Dr Offit response to delaying 2nd dose
6:59 Necessity for 2nd dose and messaging
13:57 Effect on immune response
14:34 Legal ramifications
15:42 Have we made it too complicated?
20:30 Dr Offit response
22:11 How many vaccinations do we need in coming months
24:53 Supply and distribution of vaccines
28:20 Upcoming VRBPAC meetings and adenovirus vaccines
29:57 Comparing vaccines with different efficacy
31:13 Moderna adverse reactions
32:40 What we can learn from Israel
35:58 Vaccine rollout at UC San Francisco
38:47 SARS-CoV-2 variants and vaccine efficacy
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire.
• Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwor
Follow the JAMA Network
• https://www.jamanetwork.com
• https://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.